CLOV — Clover Health Investments, Corp.

Clover Health Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Membership Growth: Clover Health reported a 38% year-over-year increase in Medicare Advantage membership, reaching approximately 140,000 members by year-end.
• Revenue: Q4 insurance revenue was $486 million, up 47% year-over-year, while total revenue for 2025 was $1.9 billion, reflecting a 41% increase.
• Adjusted EBITDA: The company achieved full-year adjusted EBITDA profitability of $22 million, with adjusted net income of $20 million.
• Consolidated Gross Profit: For 2025, consolidated gross profit was $356 million, with a new metric introduced for guidance.
• Medical Cost Trends: Medical cost trends were well controlled at 5% year-over-year, despite industry-wide pressures.

2. Strategic Updates and Business Highlights

• Cohort Economics: Clover emphasized strong cohort economics, with returning member contribution profit at $200 PMPM and new member contribution loss improving to $145 PMPM.
• Clover Assistant: Over two-thirds of members received care from Clover Assistant-powered physicians, which is expected to enhance clinical outcomes and cost management.
• Market Positioning: Clover's model is positioned to capture market share as competitors face regulatory pressures and reduced benefits.
• Counterpart Health: The company aims to expand the Counterpart Assistant platform, targeting equal membership under both Clover Assistant and Counterpart Assistant.

3. Forward Guidance and Outlook

• 2026 Expectations: Clover anticipates Medicare Advantage membership to average between 154,000 and 158,000, representing a 46% growth year-over-year.
• Revenue Projections: Total revenue is expected to be between $2.810 billion and $2.920 billion, with consolidated gross profit projected between $470 million and $510 million.
• Profitability Goals: The company expects to achieve its first full year of GAAP net income profitability in 2026, with net income projected between breakeven and $20 million.

4. Bad News, Challenges, or Points of Concern

• Gross Profit Margin Decline: There was a noted decline in gross profit margin by 150 basis points year-over-year, attributed to the dilutive impact of new member cohorts.
• Regulatory Risks: Concerns were raised about the risk adjustment model changes and potential data gaps for new members switching plans, which may impact profitability.
• Operational Pressures: Increased utilization in outpatient settings and seasonal pressures related to Part D were highlighted as ongoing challenges.

5. Notable Q&A Insights

• Cohort Performance: Management expressed confidence in the profitability of new members aligning with expectations, despite early-year pressures.
• Counterpart Health Contribution: While no immediate financial impact from Counterpart Health was disclosed, management is focused on scaling its adoption.
• Clover Assistant Engagement: There is a goal to maintain high engagement levels with Clover Assistant, even as new members are added, particularly in core markets.

In summary, Clover Health demonstrated strong financial performance in 2025, with significant membership growth and profitability. However, challenges related to gross profit margins and regulatory changes present potential headwinds as the company looks to expand in 2026 and beyond.